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Abstract 
AIM: To compare magnetic resonance imaging (MRI) with clinical examination for the detection of muscle 
abnormality in patients with muscular dystrophy. 
METHODS: Muscle power in 20 patients with a variety of forms of muscular dystrophy was examined 
clinically using the Medical Research Council (MRC) grading scale, and patients were subsequently imaged 
with MRI. MRI and clinical examination for the detection of muscle normality and abnormality were compared 
using a McNemar chi-squared test to examine differences between the two methods. 
RESULTS: MRI demonstrated radiological evidence of muscle abnormality more often than clinical 
examination; 50% of movements assessed as normal on clinical examination were associated with muscle 
abnormalities on MRI, including a significant proportion where there was severe radiological abnormality, 
indicating that focally advanced disease may be undetectable clinically. 
CONCLUSION: The combination of clinical examination and MRI could improve the accuracy of phenotypic 
characterization of patients with muscular dystrophy, and this in turn could allow a more focussed molecular 
analysis through muscle biopsy or genetic investigation. This may also be very helpful in the assessment of 
the degree of muscle compromise not only in the early phases of the disease but especially during follow-up 
and can be used in therapeutic trials. 
  
 Introduction 
The diagnosis of specific subtypes of muscular dystrophy is of fundamental importance because of their 
varied prognoses, inheritance patterns, and complications.1 Diagnosis of specific categories of muscular 
dystrophy based on clinical examination alone is frequently difficult because of the wide phenotypic overlap 
between genetically distinct disorders.2,3 Muscle biopsy is invasive and may not provide definitive diagnosis, 
and despite significant recent advances in molecular biology a genetic diagnosis is frequently not possible 
because the underlying gene defect is not known, or because the tests are not available in the diagnostic 
setting. 
Additional information from other sources would be helpful in reaching a phenotypic diagnosis, and to enable 
a hierarchy in the molecular and genetic investigations to be established. 
Cross-sectional imaging is of potential benefit in improving the clinical characterization of muscular 
dystrophies before muscle biopsy and genetic analysis, based on the knowledge that there are differing 
patterns of muscle involvement on imaging studies in various types of dystrophy. The use of computed 
tomography (CT) and magnetic resonance imaging (MRI) to document selective muscle involvement in 
differing muscular dystrophies has been reported, 4-12 but its use as a diagnostic tool in routine clinical 
practice has not been established. A gold standard is yet to be defined.  One report has suggested that 
cross-sectional imaging can detect evidence of muscle abnormality before this is manifested clinically.13  In 
addition, cross-sectional imaging can detect selective abnormality within individual muscles that may be 
difficult to detect clinically because of the presence of unaffected synergistic muscles.13 This would suggest 
that cross-sectional imaging is a sensitive means of detecting pathological muscle involvement, and that it 
may provide additional information to the clinical examination, thereby improving the phenotypic 
characterization of muscle disorders. The purpose of the present study was to compare MRI with clinical 
examination for the detection of muscle abnormality in patients with muscular dystrophy. 
  
Methods 
Twenty consecutive patients (12 males and eight females, aged 12-55 years, average 29 years) presenting 
to our centre with muscle dystrophy were included in the study. The final diagnoses in this cohort were limb 
girdle dystrophy (nine cases), distal myopathy (six cases), facioscapulohumeral dystrophy (two cases), 
autosomal dominant Emery Dreyfuss muscular dystrophy (two cases), and Becker’s muscular dystrophy (one 
case). Final diagnosis was made on the basis of clinical assessment, muscle biopsy and genetic analysis. 
Assessment of muscle abnormality was limited to the lower limbs, because of the relative ease of imaging 
the pelvic girdle and legs as compared with the shoulder girdle and arms. 
In each patient, muscle strength within the lower limb was assessed using the Medical Research Council 
(MRC) scale14 for nine movements (including hip, knee and ankle movements). These constituted hip 
abduction, adduction, flexion and extension, knee flexion and extension, and ankle eversion, dorsiflexion, 
and plantarflexion. There were therefore 180 movements available for assessment (right side only). 
Examination was performed on each occasion by a consultant neurologist experienced in the assessment of 
muscle disease. Power was defined as abnormal if the MRC grading was 4 or less. 
Each patient was imaged within a week of clinical examination using a 1.5 T MRI machine (Intera, Philips, 
Netherlands). Axial T1 imaging [Repetition time (TR) 525 ms, echo time (TE) 14 ms, contiguous 6 mm 
section thickness, acquisition time 8:56 min] was obtained in each case from the pelvic girdle to the ankles 
using a body coil. T1 imaging was chosen because of its sensitivity to fatty infiltration, and this protocol 
was in line with current trends in imaging of muscular dystrophy, at the time of the study.15,16 Twenty pre-
defined muscles were evaluated. Individual muscles were subjectively assessed for the presence or 
otherwise of abnormal fatty infiltration, as manifested by increase in T1 signal intensity within the muscle. 
An abnormal signal was classified as mild if only traces of increased signal could be observed in otherwise 
well-preserved muscle, moderate if there was significant but less than 50% involvement of the affected 
muscle, and severe if greater than 50% of the muscle was affected. This assessment was in line with many 
recent publications on grading muscle abnormality using MRI.15-17 MRI analysis was performed with 
blinding to the clinical findings or diagnosis. Two experienced radiologists performed assessment by 
consensus in line with similar methodology previously published.15-17 Observer variability was therefore not 
analysed. Local ethics approval and patients’ consent had been obtained. 
For the purpose of comparison of radiological and clinical findings, the individual muscles assessed using 
MRI were arranged into groups corresponding to each clinically analysed movement, as shown in Table 1. 
Radiological abnormality of the muscle group as a whole was judged to be present if there was abnormality 
(fatty infiltration) of any of the muscles within that group. In addition, the range of severity of radiological 
abnormality was analysed for each level of MRC grading for each of the 180 analysed movements, taking 
note of the most severely affected muscle within the respective muscle grouping. 
MRI and clinical examination for the detection of muscle normality and abnormality were compared the 
McNemar chi-squared to examine differences between the two methods. 
  
 Results 
The two-by-two contingency table for muscle group normality and abnormality as assessed by clinical 
examination and by MRI is shown in Table 2. The frequency of abnormalities detected using MRI was in 54 
of 108 (50%) of muscle groups in which clinical examination was normal, and 62 of 72 (86%) muscle groups 
in which clinical examination was abnormal. Nine out of the 20 patients had abnormal MRI findings in one or 
more individual muscles in that muscle group when the clinical examination was normal in that patient. Two 
patients had normal clinical examination and MRI findings. There was a significant difference between the 
two methods in their ability to detect abnormality (McNemar chi-square ¼ 28.89, P < 0.00001). MRI was more 
likely to show abnormality than the clinical examination. The movements most affected were knee flexion and 
extension and hip abduction and adduction. The commonest muscles showing radiological abnormality in the 
presence of a normal clinical examination were semitendinosus, semimembranosus, biceps femoris, vastus 
medialis, vastus lateralis, the gluteal muscles, and sartorius. 
In 18 muscle groups, abnormality was detected on clinical examination but not on MRI. In each case, muscle 
power had been assessed as MRC grade 4. There was no clear pattern discernible in these cases in terms 
of affected muscle groups. 
The range of severity of muscle involvement on MRI for each of the MRC grades is listed in Table 3. There is 
a clear trend between worsening MRC grade and severity of abnormality on MRI. Several further important 
observations can be made. First, of the 50% of muscle groups demonstrating radiological abnormality 
despite normal MRC grading (grade 5), over half contained muscles that were severely affected on MRI. 
Second, of the 54 muscle groups in which power was assessed as 3 or less, all showed abnormality on MRI 
in the respective muscle groups. 
  
Discussion 
This study indicates that MRI demonstrates radiological evidence of muscle abnormality more often than 
clinical examination; 50% of movements assessed as normal on clinical examination were associated with 
muscle abnormalities on MRI. The greater likelihood of cross-sectional imaging to detect muscle 
abnormality is as a result of the ability of imaging to assess individual muscles. In contrast, clinical 
examination is limited to the assessment of movements to which groups of muscles contribute. For 
instance, abnormality can be detected within an individual muscle within the adductor and quadriceps 
muscle groups in the upper leg and posterior compartment of the lower leg without being detectable 
clinically (Figs. 1-3). Normal muscle was accepted as that with no evidence of MRI signal changes in the 
muscular dystrophy patients. Furthermore, severe muscle involvement on MRI was demonstrated in a 
significant proportion of cases in which MRC grading was normal, indicating that focally advanced disease 
is not infrequently undetectable clinically. 
A number of studies have shown that MRI is more likely than CT to demonstrate fatty replacement in 
muscles, and this is likely to account for the higher detection rate of muscle involvement in the present 
study.18-20 The signal intensity difference between muscle and fat is significant, and this results in the ready 
subjective detection of fatty involvement. MRI also has the advantage of avoiding ionizing radiation, an 
important consideration in the use of imaging in clinical practice. 
In a small number of cases, abnormality was not identified using MRI in patients with decreased power (MRC 
grade 4) clinically. This may reflect the subjective nature of the MRI analysis based on our interpretation of 
fatty infiltration on MRI findings. A quantitative analysis of signal change within the individual muscles may 
have improved the sensitivity of MRI further.6 However, in no case in which muscle power was reduced to 
MRC grade 3 or less did MRI fail to demonstrate corresponding muscle abnormality. 
The observation that MRI is more sensitive to muscle abnormality than clinical examination has potentially 
important implications for the evaluation of patients with primary muscle disorders, and particularly in the 
context of muscular dystrophy. Definitive diagnosis of dystrophy subtypes is frequently difficult, due to the 
clinical phenotypic overlap between various dystrophies (particularly in relation to limb girdle patterns of 
involvement). Although this is a small-scale study and the cohort was heterogeneous, the results reflect the 
current findings globally. It is known that the few neuromuscular disorders not diagnosed by biochemical or 
histological means may still not be diagnosed by cross-sectional means but the role of cross-sectional 
imaging will play a major role in assessing disease patterns. A number of studies describe specific patterns 
of selective muscle involvement in different subtypes.4-8, 10-12 Along with the demonstration that MRI detects 
patterns of muscle abnormality more sensitively than clinical examination, it may be that the combination of 
clinical examination and MRI will more accurately characterize individual patients’ phenotype. This in turn 
could allow a more focussed molecular analysis through muscle biopsy or specific genetic/ 
immunohistological investigations. Furthermore MRI may be useful in the accurate assessment of the degree 
of muscle compromise not only in the early phases of the disease but especially during follow-up, and can 
lend itself to therapeutic trials. 
 Tables 
Table 1 Clinically examined movements and the corresponding muscles identified on magnetic 
resonance imaging 
Clinical 
Examination 
Corresponding muscles identified on magnetic resonance imaging    
Ankle dorsiflexion Tibialis anterior Extensor hallucis 
longus 
Extensor 
digitorum long 
    
Ankle 
plantarflexion 
Gastrocnemius 
(medial head) 
Gastrocnemius 
(lateral head) 
Soleus     
Ankle eversion Peroneus longus Peroneus brevis      
Knee flexion Semi-tendinosus Semi-membranosus Biceps femoris     
Knee extension Rectus femoris Vastus medialis Vastus lateralis Vastus intermedialis    
Hip flexion Rectus femoris Vastus medialis Vastus lateralis Vastus intermedialis Iliopsoas Gracilis Sartorius 
Hip extension Semi-tendinosus Semi-membranosus Biceps femoris Gluteus maximus    
Hip abduction Gluteus medius/ 
minimus 
Sartorius      
Hip adduction Adductor magnus Gracilis      
 
 
  
Table 2 Two-by-two contingency table 
comparing clinical examination and radiological 
evaluation 
 
Clinical examination 
  Normal Abnormal 
Magnetic resonance 
imaging 
Normal 
Abnormal 
54 10 
54 62 
 
 
Table 3 Comparison of range of severity of 
muscle abnormality on magnetic resonance 
imaging with Medical Research Council (MRC) 
grading 
 
MRC Total Severity of radiological abnormality 
grading number (percent of total) 
 Normal Mild Moderate Severe 
5 108 50% 15% 9% 26% 
4 45 20% 13% 29% 38% 
3 19 0% 6% 26% 68% 
2 8 0% 0% 25% 75% 
 
 
 Figures 
Figure 1 Axial T1-weighted image through the pelvic girdle in a patient with facioscapulohumeral dystrophy. 
Total fatty replacements of the rectus femoris is present bilaterally, and subtotal replacement of the obturator 
externus and pectineus on the right. No abnormality of hip flexion or adduction was detected clinically. 
  
Figure 2 Axial T1-weighted image through the upper leg in a patient with limb-girdle muscular dystrophy 
type 2A. Extensive fatty replacement of the hamstring muscles was reflected by decrease in MRC power 
grade. However, there is subclinical bilateral fatty replacement of rectus femoris and partial fatty infiltration 
of the vastus muscles on the left. 
 
   
Figure 3 Axial T1-weighted image through the lower leg of a patient with facioscapulohumeral dystrophy. 
Bilateral fatty replacement of tibialis anterior was reflected by decrease in power of ankle dorsiflexion. 
However, fatty replacement of soleus and of the medial head of gastrocnemius on the left was not 
detected clinically. 
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